High-Dose Intravenous Immunoglobulins for the Treatment of Dermatological Autoimmune Diseases

JDDG - Journal of the German Society of Dermatology- United Kingdom

doi 10.1111/ddg.13389

Full Text

Abstract

Available in

Categories

Date

December 1, 2017

Authors

Jochen H.O. Hoffmann

Alexander H. Enk

Publisher

Wiley

Related search

The Therapeutic Uses of Intravenous Immunoglobulins in Autoimmune Rheumatic Diseases

English

Polyreactive Autoantibodies Purified From Human Intravenous Immunoglobulins Prevent the Development of Experimental Autoimmune Diseases

Laboratory Investigation

Forensic Medicine

Molecular Biology

English

High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis

Case Reports in Rheumatology

English

Intravenous High-Dose Immunotherapy: Practical Recommendations for Use in the Treatment of Neurological Disimmune Diseases

Nervno-Myshechnye Bolezni

English

Corrigendum to “High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis”

Case Reports in Rheumatology

English

High-Dose Intravenous Methylprednisolone for the Prophylactic Treatment of Cluster Headache

Multidisciplinary

English

High-Dose Intravenous Naloxone for the Treatment of Acute Ischemic Stroke

Cardiovascular Medicine

Specialized Nursing

English

Combination of High-Dose Intravenous Immunoglobulins and Itraconozole in Treating Chronic Mycotic Demyelinating Optic Neuritis

The Scientific World Journal

Molecular Biology

Environmental Science

English

Polymeric Nanoparticles-Based Topical Delivery Systems for the Treatment of Dermatological Diseases

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology

Biomedical Engineering

English